Randall J. Olsen, Ph.D. - Publications
Affiliations: | 2001 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Pathology, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2005 | Olsen RJ, Lydiatt WM, Koepsell SA, Lydiatt D, Johansson SL, Naumann S, Bridge JA, Neff JR, Hinrichs SH, Tarantolo SR. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck. Head & Neck. 27: 883-92. PMID 16158422 DOI: 10.1002/Hed.20267 | 0.563 | |||
2003 | Olsen RJ, Mazlo J, Koepsell SA, McKeithan TW, Hinrichs SH. Minimal structural elements of an inhibitory anti-ATF1/CREB single-chain antibody fragment (scFv41.4). Hybridoma and Hybridomics. 22: 65-77. PMID 12831531 DOI: 10.1089/153685903321947987 | 0.56 | |||
2002 | Olsen RJ, Tarantolo SR, Hinrichs SH. Molecular approaches to sarcoma therapy. Sarcoma. 6: 27-42. PMID 18521343 DOI: 10.1080/13577140220127530 | 0.533 | |||
2001 | Olsen RJ, Hinrichs SH. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins. Oncogene. 20: 1756-64. PMID 11313922 DOI: 10.1038/sj.onc.1204268 | 0.51 | |||
1999 | Bosilevac JM, Olsen RJ, Bridge JA, Hinrichs SH. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. The Journal of Biological Chemistry. 274: 34811-8. PMID 10574952 DOI: 10.1074/Jbc.274.49.34811 | 0.568 | |||
Show low-probability matches. |